​

Brainstorm Cell Therapeutics (BCLI) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Brainstorm Cell Therapeutics Revenue Highlights

Latest Revenue (Y)

$849.00K

Latest Revenue (Q)

$365.00K

Brainstorm Cell Therapeutics Revenue by Period

Brainstorm Cell Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$849.00K100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31--100.00%
2019-12-31$-366.00K100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31-100.00%
2007-12-31-100.00%
2006-12-31-100.00%
2005-03-31-100.00%
2004-03-31--100.00%
2003-03-31$82.89K261.96%
2002-03-31$22.90K-

Brainstorm Cell Therapeutics generated $849.00K in revenue during NA 2024, up 100.00% compared to the previous quarter, and up -231.97% compared to the same period a year ago.

Brainstorm Cell Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$365.00K-164.15%
2024-03-31$-569.00K-265.89%
2023-12-31$343.00K100.00%
2023-09-30--100.00%
2023-06-30$154.00K-130.99%
2023-03-31$-497.00K100.00%
2022-12-31--100.00%
2022-09-30$474.00K132.35%
2022-06-30$204.00K-40.00%
2022-03-31$340.00K100.00%
2021-12-31-100.00%
2021-09-30--100.00%
2021-06-30$87.00K-82.63%
2021-03-31$501.00K100.00%
2020-12-31-100.00%
2020-09-30--100.00%
2020-06-30$823.00K100.00%
2020-03-31--100.00%
2019-12-31$-366.00K-135.33%
2019-09-30$1.04M100.00%
2019-06-30-100.00%
2019-03-31--100.00%
2018-12-31$170.00K-116.65%
2018-09-30$-1.02M-1891.23%
2018-06-30$57.00K100.00%
2018-03-31--100.00%
2017-12-31$975.00K644.27%
2017-09-30$131.00K100.00%
2017-06-30-100.00%
2017-03-31--100.00%
2016-12-31$212.00K100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31-100.00%
2007-12-31--

Brainstorm Cell Therapeutics generated $365.00K in revenue during Q2 2024, up -164.15% compared to the previous quarter, and up -73.44% compared to the same period a year ago.

Brainstorm Cell Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
DAWNDay One Biopharmaceuticals$131.16M$20.07M
CNTBConnect Biopharma$26.03M-
GRIGRI Bio$21.77M$4.91M
CCCCC4 Therapeutics$20.76M-
GBIOGeneration Bio$19.89M$4.09M
CUECue Biopharma$5.49M$3.34M
HCWBHCW Biologics$2.57M$426.42K
XFORX4 Pharmaceuticals$2.56M$560.00K
HOWLWerewolf Therapeutics$1.89M$1.14M
BCLIBrainstorm Cell Therapeutics$849.00K$365.00K
CRVSCorvus Pharmaceuticals--
ALDXAldeyra Therapeutics--
ANTXAN2 Therapeutics--
BCABBioAtla-$11.00M
EWTXEdgewise Therapeutics--
TRVITrevi Therapeutics--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
PASGPassage Bio--
CELCCelcuity--
MREOMereo BioPharma Group--
CKPTCheckpoint Therapeutics--

BCLI Revenue FAQ

What is Brainstorm Cell Therapeutics’s yearly revenue?

Brainstorm Cell Therapeutics's yearly revenue for 2024 was $849K, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. BCLI's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Brainstorm Cell Therapeutics’s quarterly revenue?

Brainstorm Cell Therapeutics's quarterly revenue for Q2 2024 was $365K, a -164.15% decrease from the previous quarter (Q1 2024), and a 137.01% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $-569K, a -265.89% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). BCLI's quarterly revenue for Q4 2023 was $343K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Brainstorm Cell Therapeutics’s revenue growth rate?

Brainstorm Cell Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.